Purpose: Recently, interest in chitosan has increased due to its excellent biological properties such as biocompatibility, antibacterial effect, and rapid healing capacity. On the other hand, hydroxyapatite is used as a bone substitute in the fields of orthopedics and dentistry. The hydroxyapatite-chitosan (HA-CS) complex containing hydroxyapatite nanoparticles was developed for synergy of both biomaterials. The objective of this study was to evaluate the effect of hydroxyapatite (HA)-chitosan (CS) membrane on bone regeneration in the rat calvarial defect. Methods: Eight-millimeter critical-sized calvarial defects were created in 70 male Sprague-Dawley rats. The animals were divided into 7 groups of 10 animals and received either 1) chitosan (CS) 100% membrane, 2) hydroxyapatite (HA) 30% / CS 70% membrane, 3) HA 30% / CS 70%, pressed membrane, 4) HA 40% / CS 60% membrane, 5) HA 50% / CS 50% membrane, 6) HA 50% / CS 50%, pressed membrane, or 7) a sham -surgery control. The amount of newly formed bone from the surface of the rat calvarial defects was measured using histomorphometry, following 2-or 8-week healing intervals. Results: Surgical implantation of the HA -CS membrane resulted in enhanced local bone formation at both 2 and 8 weeks compared to the control group. The HA -CS membrane would be significantly more effective than the chitosan membrane in early bone formation. Conclusions: Concerning the advantages of biomaterials, the HA-CS membrane would be an effective biomaterial for regeneration of periodontal bone. Further studies will be required to improve the mechanical properties to develop a more rigid scaffold for the HA-CS membrane. (J Korean Acad Periodontol 2009;39:213-222) 
INTRODUCTION
The main objective of periodontal treatment is not only to relieve symptoms but also to regenerate the destroyed tissues. Many methods have been introduced for regenerating damaged periodontal tissues. Guided tissue regeneration (GTR) therapy was introduced in the 1980s to achieve a repopulation of the periodontal ligament fibroblasts, and was shown to promote periodontal regeneration. The membrane barrier used in GTR should be histocompatible, biocompatible and have the capacity for space maintenance 1) . Absorbable membrane does not require a second surgical procedure, and membrane exposure is rare.
Aquirre et al 2) showed new bone formation in bony defects using absorbable membrane. However, controlling the time of absorption is difficult and therefore could cause a localized inflammatory reaction.
In addition to the above disadvantages, poor membrane stability in the wet state causes space loss between the tooth and the membrane, producing poor
The Effects of Hydroxyapatite-Chitosan Membrane on Bone Regeneration in Rat Calvarial Defects clinical results 3) . An absorbable membrane should be used in GTR in places where exact initial closure is possible, since complete removal is difficult when exposed 4) . To solve this problem, many studies have been carried out on biodegradable membranes, and acceptable results were presented 5) . Theideal membrane should be absorbable and should not require removal after the tissue regenerates; it also should block tissue migration effectively and resist inflammatory reaction. Lastly, it must have spacemaintaining capacity.
Recently, interest in chitosan has increased due to its excellent biological properties such as biocompatibility, .
Although the healing effects of chitin and chitosan on mammalian wounds have been known for centuries, it was not until the 1960s that the ingredients were .
Other studies since have suggested that chitosan enhances the formation of bone tissue and it could be used as the matrix of tissue engineering for gin-
. Paik et al 10) reported that chitosan enhanced type Ⅰcollagen synthesis in the early stage, and fa- .
Another biomaterial of interest is hydroxyapatite, which is a major component of human bone. Hydroxyapatite is used as bone substitute in the fields of orthopedics and dentistry because of its good osteoconductivity, bioactivity and biocompatibility
12)
. But hydroxyapatite is brittle and easy to fracture so it is difficult to mould into a specific shape. The hydroxyapatite-chitosan (HA-CS) complex, containing hydroxyapatite nanoparticles, was therefore developed to overcome the original disadvantage of hydroxyapatite 13) .
Although many materials are used to regenerate periodontal tissues, there is as yet no material that satisfies all conditions. This paper reports onthe fabrication of the HA-CS membrane in diverse proportion. The objective of this study was to evaluate bone regeneration capacity of HA-CS membrane in rat calvarial defects. We used one-way ANOVA, Least Significant Difference (LSD)method and paired t-test for statistical analysis.
MATERIALS AND METHODS

RESULTS
Clinical observations
Wound healing was generally uneventful and appeared similar for all nonpressed-membrane experimental groups (Exp. 1, 2, 4 and 5). In some pressed-membrane experimental groups (Exp. 3 and 6), slight inflammatory reaction was observed at 2 weeks, but inflammation was not detected at 8 weeks.
Material exposure or other complications of the surgical sites were not observed.
Histologic observations
1) Control
At 2 and 8 weeks post-surgery, defects filled with thin, loose connective tissue, with minimal new bone formation originating from the defect margins, were observed. The defect center had collapsed (Fig. 2) .
2) Experimental groups
Inboth the chitosan-only and HA-CS membrane groups, the defects were filled with loose or dense, fibrous connective tissue, and limited new bone for- mation was observed at the defect margins at 2 weeks.
A large number of residual chitosan fibers and hydroxyapatite particles were observed within the new bone at 2 weeks (Fig. 3) , but there appeared to be fewer of these at 8 weeks (Fig. 4) . Irrespective of the hydroxyapatite and chitosan dose levels, all defect sites exhibited bone formation, and volume was increased. At 8 weeks, the appearance of the new bone was more lamellar than that observed at 2 weeks.
Membrane remnants are composed of chitosan fibers and hydroxyapatite particles. The membrane remnants were surrounded by connective tissue. As the HA dose of membrane increased, the size of membrane remnants had decreased at 8 weeks.
Histometric analysis
Three animals were excluded from the histometric analysis due to technical complications in the histologic processing. Only limited new bone formation was observed in the controls. Irrespective of the HA-CS dose, there were no significant differences in % defect closure at either 2 or 8 weeks post-surgery. There was also no statistically significant difference between (Fig. 5, 6 ). Augmented areas were significantly decreased from 2 weeks to 8 weeks post-surgery in the pressed-membrane group (Fig. 7, 10 ).
New bone formation for the 50% HA dose groups (Exp. 5 and Exp. 6) at 2 weeks post-surgery was significantly greater than for the HA 0% group (Exp. 1) or HA 30% group (Exp. 2). There were significant differences between 2 and 8 weeks in new bone formation in HA 0% group (Exp. 1) and HA 30% group (Exp. 2). But Exp. 5 and Exp. 6, which received the high HA dose, were not statistically significant.
DISCUSSION
Many absorbable membranes made of collagen or various kinds of polymers, including chitosan, have been developed to the present day, and many studies on their healing effects have been carried out [14] [15] [16] [17] .
Chitosan is known to accelerate cell migration and tissue maturation, leading to wound healing; therefore, many studies relating to this property are being undertaken in thefields of dentistry and orthopedic surgery. Chitosan could be adhesive to bioactive materials such as PDGF and BMP, and thus could be widely used clinically in addition to bone substitutes and barriers 18) . The nano type of hydroxyapatite can also be attached to chitosan fibers. Nano-sized HP may have other special properties due to its small size and huge specific surface area. 19) have demonstrated a significant in- . Some researchers experimented with a composite of chitosan and nano-HA paste, but it did not have porosity and could not be loaded with cells.
Webster et al
Others have reported that fibrous scaffolds had a much greater surface-to-volume ratio than scaffolds with solid pore walls, which might have further increased protein adsorption capacity 21, 22) .
In this study, we attempted to show the clinical efficacy of a newly-formed fibrous hydroxyapatitechitosan (HA-CS) membrane in a rat model. The experimental model used in this study has been shown to be effective for evaluating the potential for bone formation [23] [24] [25] . The rat calvarial defect model is convenient for examining bone regeneration because of its effective accessibility and lack of fixation requirements.
In our histometric analysis, the length and the area Ideally, the bone substitute should conduct or induce bone formation at the same time as it is completely resorbed and substituted by bone tissue.
Evidence from previous studies suggests that HA resorption can be mediated by cells or by disintegration through the action of extracellular fluids 28, 29) . Our histologic study also showed the presence of multinuclear giant cells in close contact with the HA and chitosan surface and bone formation adjacent to the particles. Liljensten et al 30) stated that even for HAs considered absorbable, the resorption process is slow and its finalization is not well determined. The augmented area of the pressed-membrane groups (Exp. 3 and Exp. 6) was significantly decreased after 8 weeks. As the HA dose increased, the augmented areas decreased at 8 weeks because the HA nanoparticles were absorbed earlier than the chitosan fiber.
From a histological view, it seems that the membrane lacked any major role as a scaffold. There was no statistical significance in defect closure that we could evaluate from length-growth of cells. Therefore, it appears that the HA-CS membrane does not stimulate cell migration to the center of defect. In summary, HA-CS membrane could collapse early in the healing period and seems to interfere in the formation of new bone in the central zone of surgical defects.
The pressed-membrane groups were developed primarily to overcome the weak mechanical properties of the conventional membranes and to be easy to handle.
After the pressed-membrane absorbed water, however, there was no difference in handling from non-pressed, conventional membranes. Furthermore, pressed-membrane showed swollen shape at 2 weeks after surgery.
To play a leading role in a scaffold, membranes should have improved mechanical properties in terms of water absorption.
In summary, surgical implantation of the HA-CS membrane resulted in enhanced local bone formation at both 2 and 8 weeks compared to the control group.
The results suggest that the addition of HA accelerated new bone formation as seen in Table 3 . Further studies will be required to improve the mechanical properties for development of a more rigid, pressed scaffold for the HA-CS membrane.
